This subject phenotype table contains de-identified Subject ID, patient's cohort in current study, tumor histology, age, sex, smoking status and pack years, PD-L1 protein expression, prior courses of cytotoxic chemotherapy, pembrolizumab dose and administration, progression free survival, best overall response to pembrolizumab, durable clinical benefit and molecular smoking signature.

pht005053
Beschreibung

pht005053

Alias
UMLS CUI [1,1]
C3846158
De-identified Subject ID
Beschreibung

SUBJECT_ID

Datentyp

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
Patient's cohort in current study
Beschreibung

Cohort

Datentyp

string

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0947630
Tumor histology
Beschreibung

Histology

Datentyp

string

Alias
UMLS CUI [1,1]
C1516204
Patient's age
Beschreibung

Age

Datentyp

text

Maßeinheiten
  • years
Alias
UMLS CUI [1,1]
C0001779
years
Gender of participant
Beschreibung

Sex

Datentyp

text

Alias
UMLS CUI [1,1]
C0079399
Self-reported smoking status
Beschreibung

Smoking

Datentyp

string

Alias
UMLS CUI [1,1]
C1519386
UMLS CUI [1,2]
C2700446
Product of number of packs per day and number of years smoked
Beschreibung

Pack-years

Datentyp

text

Alias
UMLS CUI [1,1]
C3694145
UMLS CUI [1,2]
C4288114
Programmed death-ligand 1 (PD-L1) expression
Beschreibung

PD-L1

Datentyp

string

Alias
UMLS CUI [1,1]
C5781048
Prior courses of cytotoxic chemotherapy. Combination chemotherapy counted as a single course. No patient had received prior immunotherapy.
Beschreibung

Priors

Datentyp

text

Alias
UMLS CUI [1,1]
C1302181
UMLS CUI [1,2]
C0237753
UMLS CUI [2,1]
C1521750
UMLS CUI [2,2]
C0750729
UMLS CUI [2,3]
C0205447
UMLS CUI [3,1]
C1298908
UMLS CUI [3,2]
C1514463
UMLS CUI [3,3]
C0021083
Dose (mg/kg)
Beschreibung

Dose (mg/kg)

Datentyp

text

Alias
UMLS CUI [1,1]
C3174092
Pembrolizumab dosed every 2 or 3 weeks as indicated.
Beschreibung

Sched

Datentyp

text

Alias
UMLS CUI [1,1]
C3658706
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1561548
Progression free survival in months
Beschreibung

PFS (mos)

Datentyp

text

Maßeinheiten
  • months
Alias
UMLS CUI [1,1]
C0242792
UMLS CUI [1,2]
C0439231
months
Denotes best overall response to pembrolizumab
Beschreibung

Resp

Datentyp

string

Alias
UMLS CUI [1,1]
C2986560
UMLS CUI [1,2]
C3658706
UMLS CUI [1,3]
C0087111
Patient's clinical benefit
Beschreibung

Durable_Clinical_Benefit

Datentyp

string

Alias
UMLS CUI [1,1]
C4684590
Molecular smoking signature
Beschreibung

Smoking_Signature

Datentyp

string

Alias
UMLS CUI [1,1]
C1704864
UMLS CUI [1,2]
C0037369

Ähnliche Modelle

This subject phenotype table contains de-identified Subject ID, patient's cohort in current study, tumor histology, age, sex, smoking status and pack years, PD-L1 protein expression, prior courses of cytotoxic chemotherapy, pembrolizumab dose and administration, progression free survival, best overall response to pembrolizumab, durable clinical benefit and molecular smoking signature.

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
pht005053
C3846158 (UMLS CUI [1,1])
SUBJECT_ID
Item
De-identified Subject ID
string
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Cohort
Item
Patient's cohort in current study
string
C0599755 (UMLS CUI [1,1])
C0947630 (UMLS CUI [1,2])
Histology
Item
Tumor histology
string
C1516204 (UMLS CUI [1,1])
Age
Item
Patient's age
text
C0001779 (UMLS CUI [1,1])
Item
Gender of participant
text
C0079399 (UMLS CUI [1,1])
Code List
Gender of participant
CL Item
Female (F)
C0086287 (UMLS CUI [1,1])
CL Item
Male (M)
C0086582 (UMLS CUI [1,1])
CL Item
Not applicable (NA)
C1272460 (UMLS CUI [1,1])
CL Item
Other (Oth)
CL Item
Unknown (UNK)
Smoking
Item
Self-reported smoking status
string
C1519386 (UMLS CUI [1,1])
C2700446 (UMLS CUI [1,2])
Pack-years
Item
Product of number of packs per day and number of years smoked
text
C3694145 (UMLS CUI [1,1])
C4288114 (UMLS CUI [1,2])
PD-L1
Item
Programmed death-ligand 1 (PD-L1) expression
string
C5781048 (UMLS CUI [1,1])
Priors
Item
Prior courses of cytotoxic chemotherapy. Combination chemotherapy counted as a single course. No patient had received prior immunotherapy.
text
C1302181 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1521750 (UMLS CUI [2,1])
C0750729 (UMLS CUI [2,2])
C0205447 (UMLS CUI [2,3])
C1298908 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
C0021083 (UMLS CUI [3,3])
Dose (mg/kg)
Item
Dose (mg/kg)
text
C3174092 (UMLS CUI [1,1])
Sched
Item
Pembrolizumab dosed every 2 or 3 weeks as indicated.
text
C3658706 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1561548 (UMLS CUI [1,3])
PFS (mos)
Item
Progression free survival in months
text
C0242792 (UMLS CUI [1,1])
C0439231 (UMLS CUI [1,2])
Resp
Item
Denotes best overall response to pembrolizumab
string
C2986560 (UMLS CUI [1,1])
C3658706 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Durable_Clinical_Benefit
Item
Patient's clinical benefit
string
C4684590 (UMLS CUI [1,1])
Smoking_Signature
Item
Molecular smoking signature
string
C1704864 (UMLS CUI [1,1])
C0037369 (UMLS CUI [1,2])